Cited by 2,337Pancreatic and Hepatic Oncology ResearchGenetic factors in colorectal cancerCancer-related Molecular Pathways

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

Hahn, Stephan A., Schutte, Mieke, Shamsul Hoque, A. T. M., Moskaluk, Christopher A., da Costa, Luis T., Rozenblum, Ester, Weinstein, Craig L., Fischer, Aryeh, Yeo, Charles J., Hruban, Ralph H., Kern, Scott E.·1996·Science

DOI 10.1126/science.271.5247.350

Open this paper in CoChat — free account

Abstract

About 90 percent of human pancreatic carcinomas show allelic loss at chromosome 18q. To identify candidate tumor suppressor genes on 18q, a panel of pancreatic carcinomas were analyzed for convergent sites of homozygous deletion. Twenty-five of 84 tumors had homozygous deletions at 18q21.1, a site that excludes DCC (a candidate suppressor gene for colorectal cancer) and includes DPC4 , a gene similar in sequence to a Drosophila melanogaster gene ( Mad ) implicated in a transforming growth factor-β (TGF-β)-like signaling pathway. Potentially inactivating mutations in DPC4 were identified in six of 27 pancreatic carcinomas that did not have homozygous deletions at 18q21.1. These results identify DPC4 as a candidate tumor suppressor gene whose inactivation may play a role in pancreatic and possibly other human cancers.

Integrity signals

Registry

Crossref · 10.1126/science.271.5247.350

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S. D., Wang, J., Myeroff, L. L., Parsons, R. E., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,267
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Almoguera, C., Shibata, D. K., Forrester, K., Wj, M., Arnheim, N., & Perucho, M. (1988) · Cell · doi:10.1016/0092-8674(88)90571-5 · Cited by 2,122
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Tumor Suppressor Genes
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,765
Identification of a Chromosome 18q Gene that Is Altered in Colorectal Cancers
Fearon, E. R., Cho, K. R., Nigro, J. M., Kern, S. E., Simons, J. W., Ruppert, J. M., Hamilton, S. R., Preisinger, A. C., Thomas, G., Kinzler, K. W., et al. (1990) · Science · doi:10.1126/science.2294591 · Cited by 1,760
Self-citation
The Molecular Genetics of Cancer
Bishop, J. M. (1987) · Science · doi:10.1126/science.3541204 · Cited by 1,674
Hereditary cancer, oncogenes, and antioncogenes.
Knudson, A. G. (1985) · PubMed · Cited by 1,218
Thermal asymmetric interlaced PCR: automatable amplification and sequencing of insert end fragments from P1 and YAC clones for chromosome walking
Liu, Y., & Whittier, R. F. (1995) · Genomics · doi:10.1016/0888-7543(95)80010-j · Cited by 1,141
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M. E. M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,132
Self-citation

Show all 25 references

Research works printed but not linked: 2

HAHN A. S., IN PRESS CANCER RES .
LEACH S. F., COMMUNICATION .

Sorted by citations

Items 201–300 of 1,002

PTGF-β , a type β transforming growth factor (TGF-β) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-β signaling pathway
Tan, M., Wang, Y., Guan, K., & Sun, Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.109 · Cited by 257
Expression of a dominant‐negative mutant TGF‐β type II receptor in transgenic mice reveals essential roles for TGF‐β in regulation of growth and differentiation in the exocrine pancreas
Böttinger, E. P., Jakubczak, J. L., Roberts, I. S. D., Mumy, M., Hemmati, P., Bagnall, K., Merlino, G., & Wakefield, L. M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2621 · Cited by 253
The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
T. H. B. C. S. G., Iqbal, J., Ragone, A., Lubinski, J., Lynch, H. T., Moller, P., Ghadirian, P., Foulkes, W. D., Armel, S., Eisen, A., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.483 · Cited by 252
TGFβ-related pathways
Patterson, G. I., & Padgett, R. W. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01916-2 · Cited by 257
Secretome proteomics for discovery of cancer biomarkers
Makridakis, M., & Vlahou, A. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.07.001 · Cited by 250
Overexpression and Activation of the Tyrosine Kinase Src in Human Pancreatic Carcinoma
Lutz, M. P., Eßer, I. B. S., Flossmann-Kast, B. B. M., Vogelmann, R., Lührs, H., Friess, H., Büchler, M. W., & Adler, G. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.8043 · Cited by 248
Update on pancreatic intraepithelial neoplasia.
Hruban, R. H., Maitra, A., & Goggins, M. (2008) · PubMed Central · Cited by 245
Self-citation
The type III TGF-β receptor suppresses breast cancer progression
Dong, M., How, T., Kirkbride, K. C., Gordon, K. J., Lee, J. D., Hempel, N., Kelly, P., Moeller, B. J., Marks, J. R., & Blobe, G. C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29293 · Cited by 248
Regulation of Smad7 Promoter by Direct Association with Smad3 and Smad4
Nagarajan, R. P., Zhang, J., Li, W., & Chen, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33412 · Cited by 248
Role of Smad4 (DPC4) inactivation in human cancer
Miyaki, M., & Kuroki, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01066-0 · Cited by 242
c-myc Is a Downstream Target of the Smad Pathway
Yagi, K., Furuhashi, M., Aoki, H., Goto, D., Kuwano, H., Sugamura, K., Miyazono, K., & Kato, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m104170200 · Cited by 248
Somatic Mutation Profiles of MSI and MSS Colorectal Cancer Identified by Whole Exome Next Generation Sequencing and Bioinformatics Analysis
Timmermann, B., Kerick, M., Roehr, C., Fischer, A., Isau, M., Boerno, S. T., Wunderlich, A., Barmeyer, C., Seemann, P., Koenig, J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015661 · Cited by 246
Self-citation
Targeting the TGFβ signaling network in human neoplasia
Dumont, N., & Arteaga, C. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00135-1 · Cited by 243
Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer
Jung, B. H., Staudacher, J. J., & Beauchamp, D. R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.10.015 · Cited by 250
Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers.
Nagatake, M., Takagi, Y., Osada, H., Uchida, K., Mitsudomi, T., Saji, S., Shimokata, K., Takahashi, T., & Takahashi, T. (1996) · PubMed · Cited by 241
Allelic Loss Is Often the First Hit in the Biallelic Inactivation of the p53 and DPC4 Genes During Pancreatic Carcinogenesis
Luettges, J., Galehdari, H., Bröcker, V., Schwarte‐Waldhoff, I., Henne‐Bruns, D., Klöppel, G., Schmiegel, W., & Hahn, S. A. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64123-5 · Cited by 241
Self-citation
Overexpression of the TGFbeta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells.
Tachibana, I., Imoto, M., Adjei, P. N., Gores, G. J., Subramaniam, M., Spelsberg, T. C., & Urrutia, R. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119418 · Cited by 241
Control of the cell cycle and apoptosis
Lundberg, A. S., & Weinberg, R. A. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00292-0 · Cited by 244
Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice
Xu, X., Brodie, S. G., Yang, X. Y., Im, Y., Parks, W. T., Chen, L., Zhou, Y., Weinstein, M., Kim, S., & Deng, C. (2000) · Oncogene · doi:10.1038/sj.onc.1203504 · Cited by 238
Molecular Pathogenesis of Pancreatic Cancer
Grant, T. J., Hua, K., & Singh, A. (2016) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2016.09.008 · Cited by 237
Immunohistochemically Detected Expression of 3 Major Genes (CDKN2A/p16, TP53, and SMAD4/DPC4) Strongly Predicts Survival in Patients With Resectable Pancreatic Cancer
Oshima, M., Okano, K., Muraki, S., Haba, R., Maeba, T., Suzuki, Y., & Yachida, S. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182827a65 · Cited by 236
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. E. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 236
Role of Growth Factors in Pancreatic Cancer
Korc, M. (1998) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30283-7 · Cited by 234
Direct Interaction of c-Myc with Smad2 and Smad3 to Inhibit TGF-β-Mediated Induction of the CDK Inhibitor p15Ink4B
Feng, X., Liang, Y.-Y., Liang, M., Zhai, W., & Lin, X. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00430-0 · Cited by 232
Pancreatic carcinoma
Eosewicz, S., & Wiedenmann, B. J. (1997) · The Lancet · doi:10.1016/s0140-6736(96)05523-7 · Cited by 231
Role of TAK1 and TAB1 in BMP signaling in early Xenopus development
Shibuyà, H., Iwata, H., Masuyama, N., Gotoh, Y., Yamaguchi, K., Irie, K., Matsumoto, K., Nishida, E., & Ueno, N. (1998) · The EMBO Journal · doi:10.1093/emboj/17.4.1019 · Cited by 230
The corepressor CtBP interacts with Evi-1 to repress transforming growth factor β signaling
Izutsu, K., Kurokawa, M., Imai, Y., Maki, K., Mitani, K., & Hirai, H. (2001) · Blood · doi:10.1182/blood.v97.9.2815 · Cited by 227
The Protein Interaction Landscape of the Human CMGC Kinase Group
Varjosalo, M. T., Keskitalo, S., van Drogen, A., Nurkkala, H., Vichalkovski, A., Aebersold, R. H., & Gstaiger, M. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.027 · Cited by 235
TGF β Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis
Papageorgis, P. (2015) · Journal of Oncology · doi:10.1155/2015/587193 · Cited by 228
Mad acts downstream of Dpp receptors, revealing a differential requirement for dpp signaling in initiation and propagation of morphogenesis in the Drosophila eye
Wiersdorff, V., Lecuit, T., Cohen, S. M., & Mlodzik, M. (1996) · Development · doi:10.1242/dev.122.7.2153 · Cited by 224
The Role of Pancreatic Cyst Fluid Molecular Analysis in Predicting Cyst Pathology
Khalid, A., McGrath, K. M., Zahid, M., Wilson, M., Brody, D., SWALSKY, P., Moser, A. J., Lee, K. K., Slivka, A., Whitcomb, D. C., et al. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00409-x · Cited by 223
Bone morphogenetic protein receptors
Yamashita, H., ten Dijke, P., Heldin, C., & Miyazono, K. (1996) · Bone · doi:10.1016/s8756-3282(96)00259-1 · Cited by 221
Smad1 and Smad5 Act Downstream of Intracellular Signalings of BMP-2 That Inhibits Myogenic Differentiation and Induces Osteoblast Differentiation in C2C12 Myoblasts
Yamamoto, N., Akiyama, S., Katagiri, T., Namiki, M., Kurokawa, T., & Suda, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7325 · Cited by 219
Molecular biology of colorectal cancer
Gryfe, R., Bapat, B. V., Gallinger, S., Swallow, C. J., Redston, M. S., & Couture, J. (1997) · Current Problems in Cancer · doi:10.1016/s0147-0272(97)80003-7 · Cited by 224
Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way
Santarosa, M., & Ashworth, A. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.01.001 · Cited by 220
Regulation of differentiation by TFG-β
Moses, H. L., & Serra, R. A. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)80087-6 · Cited by 216
NF-κB promotes epithelial–mesenchymal transition, migration and invasion of pancreatic carcinoma cells
Maier, H. J., Schmidt-Straßburger, U., Huber, M. A., Wiedemann, E. M., Beug, H., & Wirth, T. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.03.003 · Cited by 215
Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation
Bornstein, S., White, R. A., Malkoski, S. P., Oka, M., Han, G., Cleaver, T. G., Reh, D. D., Andersen, P. E., Gross, N. D., Olson, S. B., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38854 · Cited by 216
TGF-β–induced Phosphorylation of Smad3 Regulates Its Interaction with Coactivator p300/CREB-binding Protein
Shen, X., Hu, P. P.-C., Liberati, N. T., Datto, M., Frederick, J. P., & Wang, X. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.12.3309 · Cited by 214
Targeting TGF-β signaling in cancer
Katz, L. H., Li, Y., Chen, J.-S., Muñoz, N. M., Majumdar, A., Chen, J., & Mishra, L. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.782287 · Cited by 212
On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?
Teixeira, A. F., ten Dijke, P., & Zhu, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00605 · Cited by 216
The pancreatic cancer genome revisited
Hayashi, A., Hong, J., & Iacobuzio-Donahue, C. A. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00463-z · Cited by 211
Smad4 Inactivation Promotes Malignancy and Drug Resistance of Colon Cancer
Papageorgis, P., Cheng, K., Ozturk, S., Gong, Y., Lambert, A. W., Abdolmaleky, H. M., Zhou, J., & Thiagalingam, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-09-3269 · Cited by 211
Structural Basis of Heteromeric Smad Protein Assembly in TGF-β Signaling
Chacko, B. M., Qin, B. Y., Tiwari, A., Shi, G., Lam, S. S., Hayward, L. J., deCaestecker, M. P., & Lin, K. F. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.07.016 · Cited by 208
Extracellular Matrix-Associated Transforming Growth Factor-β: Role in Cancer Cell Growth and Invasion
Taipale, J., Saharinen, J., & Keski‐Oja, J. (1998) · Advances in cancer research · doi:10.1016/s0065-230x(08)60740-x · Cited by 209
A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human diseasePreprint
Wagner, M., Greten, F. R., Weber, C. K., Koschnick, S., Mattfeldt, T., Deppert, W., Kern, H. F., Adler, G., & Schmid, R. M. (2001) · Genes & Development · doi:10.1101/gad.184701 · Cited by 204
Role of TGFβ in regulation of the tumor microenvironment and drug delivery (Review)
Papageorgis, P., & Stylianopoulos, T. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2816 · Cited by 213
Heteromeric and Homomeric Interactions Correlate with Signaling Activity and Functional Cooperativity of Smad3 and Smad4/DPC4
Wu, R.-Y., Zhang, Y. E., Feng, X., & Derynck, R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2521 · Cited by 205
Comprehensive Analysis of Matrix Metalloproteinase and Tissue Inhibitor Expression in Pancreatic Cancer
Jones, L., Humphreys, M. J., Campbell, F., Neoptolemos, J. P., & Boyd, M. T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1157-03 · Cited by 202
Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice.
Takaku, K., Miyoshi, H., Matsunaga, A., Oshima, M., Sasaki, N., & Taketo, M. M. (1999) · PubMed · Cited by 202
Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer
Świerczyński, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i9.2279 · Cited by 203
Array-Based Comparative Genomic Hybridization Identifies Localized DNA Amplifications and Homozygous Deletions in Pancreatic Cancer
Bashyam, M. D., Bair, R. J., Kim, Y. H., Wang, P., Hernandez‐Boussard, T., Karikari, C. A., Tibshirani, R. J., Maitra, A., & Pollack, J. R. (2005) · Neoplasia · doi:10.1593/neo.04586 · Cited by 207
The DAF-3 Smad protein antagonizes TGF-β-related receptor signaling in the Caenorhabditis elegansdauer pathwayPreprint
Patterson, G. I., Koweek, A., Wong, A. C. K., Liu, Y., & Ruvkun, G. (1997) · Genes & Development · doi:10.1101/gad.11.20.2679 · Cited by 201
Activin Signal Transduction Pathways
Pangas, S. A., & Woodruff, T. K. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00294-0 · Cited by 200
Molecular pathogenesis of pancreatic cancer
Maitra, A., Kern, S. E., & Hruban, R. H. (2006) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.10.002 · Cited by 199
Self-citation
Transforming growth factor β signal transduction
Dennler, S., Goumans, M., & ten Dijke, P. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.5.731 · Cited by 292
Gene Expression Profiling of Microdissected Pancreatic Ductal Carcinomas Using High-Density DNA Microarrays
Grützmann, R., Pilarsky, C. P., Ammerpohl, O., Lüttges, J., Böhme, A., Sipos, B., Foerder, M., Alldinger, I., Jahnke, B., Schackert, H. K., et al. (2004) · Neoplasia · doi:10.1593/neo.04295 · Cited by 198
Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis
Moore, P. S., Orlandini, S., Zamboni, G., Capelli, P., Rigaud, G., Falconi, M., Bassi, C., Lemoine, N. R., & Scarpa, A. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1567 · Cited by 197
Inactivation of Smad4 Accelerates KrasG12D-Mediated Pancreatic Neoplasia
Kojima, K., Vickers, S. M., Adsay, V. N., Jhala, N. C., Kim, H., Schoeb, T. R., Grizzle, W. E., & Klug, C. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4167 · Cited by 197
The smad5 mutation somitabun blocks Bmp2b signaling during early dorsoventral patterning of the zebrafish embryo
Hild, M., Dick, A., Rauch, G.-J., Meier, A., Bouwmeester, T., Haffter, P., & Hammerschmidt, M. (1999) · Development · doi:10.1242/dev.126.10.2149 · Cited by 197
Ski/Sno and TGF-β signaling
Liu, X., SUN, Y., Weinberg, R. A., & Lodish, H. F. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00031-9 · Cited by 197
Specific Chromosomal Aberrations and Amplification of the AIB1 Nuclear Receptor Coactivator Gene in Pancreatic Carcinomas
Ghadimi, Β. M., Schröck, E., Walker, R. L., Wangsa, D., Jauho, A., Meltzer, P. S., & Ried, T. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65298-4 · Cited by 197
PSPC1 mediates TGF-β1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis
Yeh, H.-W., Hsu, E.-C., Lee, S.-S., Lang, Y., Lin, Y., Chang, C., Lee, S.-Y., Gu, D.-L., Shih, J., Ho, C., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0062-y · Cited by 197
Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor β signaling by targeting Smads to the ubiquitin–proteasome pathway
Xu, J., & Attisano, L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4820 · Cited by 196
Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene.
Böttinger, E. P., Jakubczak, J. L., Haines, D. C., Bagnall, K. M., & Wakefield, L. M. (1997) · PubMed · Cited by 196
Transforming Growth Factor-β1 Enhances Ha-ras-induced Expression of Cyclooxygenase-2 in Intestinal Epithelial Cells via Stabilization of mRNA
Sheng, H., Shao, J., Dixon, D. A., Williams, C. S., Prescott, S. M., DuBois, R. N., & Beauchamp, R. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6628 · Cited by 196
Activin signaling as an emerging target for therapeutic interventions
Tsuchida, K., Nakatani, M., Hitachi, K., Uezumi, A., Sunada, Y., Ageta, H., & Inokuchi, K. (2009) · Cell Communication and Signaling · doi:10.1186/1478-811x-7-15 · Cited by 202
Regulation of gonadotropin subunit gene transcription
Burger, L. L., Haisenleder, D. J., Dalkin, A. C., & Marshall, J. C. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01600 · Cited by 195
Molecular Pathways: Targeting the TGF-β Pathway for Cancer Therapy
Smith, A., Robin, T. P., & Ford, H. L. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3224 · Cited by 192
Transforming growth factor-β signal transduction in epithelial cells
Yue, J., & Mulder, K. M. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00143-7 · Cited by 196
The Discovery and Early Days of TGF-β: A Historical PerspectivePreprint
Moses, H. L., Roberts, A. B., & Derynck, R. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021865 · Cited by 198
Overexpression of cyclooxygenase-2 in carcinoma of the pancreas.
Okami, J., Yamamoto, H., Fujiwara, Y., Tsujie, M., Kondo, M., Noura, S., Oshima, S., Nagano, H., Dono, K., Umeshita, K., et al. (1999) · PubMed · Cited by 192
Array Comparative Genomic Hybridization Analysis of Colorectal Cancer Cell Lines and Primary Carcinomas
Douglas, E. J., Fiegler, H., Rowan, A., Halford, S. E. R., Bicknell, D., Bodmer, W. F., Tomlinson, I. P. M., & Carter, N. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0328 · Cited by 195
Genetics of Pancreatic Cancer
Hruban, R. H., Petersen, G. M., Ha, P. K., & Kern, S. E. (1998) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30282-5 · Cited by 194
Self-citation
Mads and Smads in TGFβ signalling
Attisano, L., & Wrana, J. L. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80141-5 · Cited by 193
A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library.
Su, G. H., Sohn, T. A., Ryu, B., & Kern, S. E. (2000) · PubMed · Cited by 189
Self-citation
Identification and mapping of human cDNAs homologous to Drosophila mutant genes through EST database searching
Banfi, S., Borsani, G., Rossi, E., Bernard, L., Guffanti, A., Rubboli, F., Marchitiello, A., Giglio, S., Coluccia, E., Zollo, M., et al. (1996) · Nature Genetics · doi:10.1038/ng0696-167 · Cited by 189
An iPSC Line from Human Pancreatic Ductal Adenocarcinoma Undergoes Early to Invasive Stages of Pancreatic Cancer Progression
Kim, J., Hoffman, J. P., Alpaugh, R. K., Rhim, A. D., Reichert, M., Stanger, B. Z., Furth, E. E., Sepulveda, A. R., Yuan, C., Won, K., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.05.036 · Cited by 198
Activins and Inhibins in Endocrine and Other Tumors
Risbridger, G. P., Schmitt, J. F., & Robertson, D. M. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.6.0450 · Cited by 188
Critical Role of Smads and AP-1 Complex in Transforming Growth Factor-β-dependent Apoptosis
Yamamura, Y., Hua, X., Bergelson, S., & Lodish, H. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006023200 · Cited by 191
Induction by transforming growth factor-β1 of epithelial to mesenchymal transition is a rare event in vitro
Brown, K. A., Aakre, M. E., Gorska, A. E., Price, J. O., Eltom, S. E., Pietenpol, J. A., & Moses, H. L. (2004) · Breast Cancer Research · doi:10.1186/bcr778 · Cited by 191
TGF-beta Signaling in Cancer Treatment
Fabregat, I., Fernando, J., Mainez, J., & Sancho, P. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990591 · Cited by 187
Molecular interactions in the Vogelstein model of colorectal carcinoma
Arends, J. W. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200003)190:4 · Cited by 184
Tumor suppressor genetics
Payne, S. R., & Kemp, C. J. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi223 · Cited by 189
Basics of TGF-ß and Pancreatic Cancer
Truty, M. J., & Urrutia, R. A. (2007) · Pancreatology · doi:10.1159/000108959 · Cited by 192
Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion.
Portella, G., Cumming, S. A., Liddell, J., Cui, W., Ireland, H., Akhurst, R. J., & Balmain, A. (1998) · PubMed · Cited by 185
Pancreatic Carcinogenesis
Koorstra, J.-B. M., Hustinx, S. R., Offerhaus, G. J. A., & Maitra, A. (2008) · Pancreatology · doi:10.1159/000123838 · Cited by 191
Novel Human and Mouse Homologs of Saccharomyces cerevisiae DNA Polymerase η
McDonald, J. P., Rapić-Otrin, V., Epstein, J. A., Broughton, B. C., Wang, X., Lehmann, A. R., Wolgemuth, D. J., & Woodgate, R. (1999) · Genomics · doi:10.1006/geno.1999.5906 · Cited by 183
The Role of Cyclooxygenase and Lipoxygenase in Cancer Chemoprevention
Cuendet, M., & Pezzuto, M. (2000) · Drug metabolism and drug interactions · doi:10.1515/dmdi.2000.17.1-4.109 · Cited by 182
Tumour suppressor gene expression correlates with gastric cancer prognosis
Lee, H. S., Lee, H. K., Kim, H. S., Yang, H., & Kim, W. H. (2003) · The Journal of Pathology · doi:10.1002/path.1288 · Cited by 180
Sequential Accumulation of K-ras Mutations and p53 Overexpression in the Progression of Pancreatic Mucinous Cystic Neoplasms to Malignancy
Jimenez, R. E., Warshaw, A. L., Z’graggen, K., Hartwig, W., Taylor, D. Z., Compton, C. C., & Castillo, C. F.-D. (1999) · Annals of Surgery · doi:10.1097/00000658-199910000-00006 · Cited by 180
Genomic Instability Is an Early Event during the Progression Pathway of Ulcerative-Colitis-Related Neoplasia
Willenbucher, R. F., Aust, D. E., Chang, C. G., Zelman, S. J., Ferrell, L. D., Moore, D. H., & Waldman, F. M. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65438-7 · Cited by 180
CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor β transcriptional responses in endothelial cells
Topper, J. N., DiChiara, M. R., Brown, J. D., Williams, A. J., Falb, D., Collins, T., & Gimbrone, M. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9506 · Cited by 180
Genetically engineered mouse models of pancreatic adenocarcinoma
Guerra, C. E., & Barbacid, M. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.02.002 · Cited by 179
Premature Luteinization and Cumulus Cell Defects in Ovarian-Specific Smad4 Knockout Mice
Pangas, S. A., Li, X., Robertson, E. J., & Matzuk, M. M. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0462 · Cited by 179
Role of tumour markers, cytogenetics
Lamerz, R. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_4.s145 · Cited by 178
Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
Tian, F., Byfield, S. D., Parks, W. T., Yoo, S. S., Felici, A., Tang, B., Piek, E., Wakefield, L. M., & Roberts, A. B. (2003) · PubMed · Cited by 177
A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3
Dennler, S., Huet, S., & Gauthier, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202729 · Cited by 176
Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo
Kleeff, J. H., Maruyama, H., Ishiwata, T., Sawhney, H., Friess, H., Büchler, M. W., & Korc, M. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70024-7 · Cited by 176
Biology of TGF-β in knockout and transgenic mouse models
Böttinger, E. P., Letterio, J. J., & Roberts, A. B. (1997) · Kidney International · doi:10.1038/ki.1997.185 · Cited by 176

Authors: Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., & Kern, S. E.
Affiliations: Johns Hopkins University (US)
S. A. Hahn, M. Schutte, A. T. M. S. Hoque, C. A. Moskaluk, E. Rozenblum, C. L. Weinstein, A. Fischer, R. H. Hruban, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
L. T. da Costa, Graduate Program in Human Genetics and Molecular Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Corresponding author: Kern, Scott E.
ORCID: Hahn, Stephan A.
Moskaluk, Christopher A.
Fischer, Aryeh
Yeo, Charles J.
Hruban, Ralph H.
Kern, Scott E.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1996-01-19
Volume: 271
Issue: 5247
Pages: 350-353
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.271.5247.350
OpenAlex: W2100522747
Cited by: 2,337
References: 25
Citations by year: 2026: 20 · 2025: 21 · 2024: 29 · 2023: 26 · 2022: 31 · 2021: 41 · 2020: 33 · 2019: 44 · 2018: 41 · 2017: 46 · 2016: 55 · 2015: 59 · 2014: 71 · 2013: 64 · 2012: 67
FWCI: 70.80
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (P50CA062924, CA 62924)
Topics: Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords: SMAD4, tumor suppressor, pancreatic cancer, homozygous deletion, loss of heterozygosity, TGF-beta signaling, loss-of-function mutations, candidate gene identification
MeSH terms: Alleles, Amino Acid Sequence, Animals, Base Sequence, Cell Division, Chromosome Mapping, Chromosomes, Human, Pair 18, DNA-Binding Proteins, Genetic Markers, Humans, Molecular Sequence Data, Mutation, Neoplasm Transplantation, Pancreatic Neoplasms, Proteins, Transplantation, Heterologous, Tumor Cells, Cultured, Signal Transduction, Trans-Activators, Gene Expression, Genes, Tumor Suppressor, Transforming Growth Factor beta, Gene Deletion, Mice, Smad4 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks